SANA logo

Sana Biotechnology (SANA) Company Overview

Profile

Full Name:

Sana Biotechnology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 4, 2021

Indexes:

Not included

Description:

Sana Biotechnology is a company focused on developing innovative therapies using gene editing and cell engineering. They aim to treat various diseases by creating new ways to repair or replace damaged cells and tissues, improving health and quality of life for patients.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Feb 29, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 8, 25 TD Cowen
Buy
Jan 8, 25 HC Wainwright & Co.
Buy
Nov 27, 24 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Nov 5, 24 JMP Securities
Market Perform
Nov 5, 24 HC Wainwright & Co.
Buy
Aug 9, 24 HC Wainwright & Co.
Buy
Aug 9, 24 Citigroup
Buy
May 9, 24 HC Wainwright & Co.
Buy
Mar 1, 24 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Sana Biotechnology?
  • Does Sana Biotechnology pay dividends?
  • What sector is Sana Biotechnology in?
  • What industry is Sana Biotechnology in?
  • What country is Sana Biotechnology based in?
  • When did Sana Biotechnology go public?
  • Is Sana Biotechnology in the S&P 500?
  • Is Sana Biotechnology in the NASDAQ 100?
  • Is Sana Biotechnology in the Dow Jones?
  • When was Sana Biotechnology's last earnings report?
  • When does Sana Biotechnology report earnings?
  • Should I buy Sana Biotechnology stock now?

What is the ticker symbol for Sana Biotechnology?

The ticker symbol for Sana Biotechnology is NASDAQ:SANA

Does Sana Biotechnology pay dividends?

No, Sana Biotechnology does not pay dividends

What sector is Sana Biotechnology in?

Sana Biotechnology is in the Healthcare sector

What industry is Sana Biotechnology in?

Sana Biotechnology is in the Biotechnology industry

What country is Sana Biotechnology based in?

Sana Biotechnology is headquartered in United States

When did Sana Biotechnology go public?

Sana Biotechnology's initial public offering (IPO) was on February 4, 2021

Is Sana Biotechnology in the S&P 500?

No, Sana Biotechnology is not included in the S&P 500 index

Is Sana Biotechnology in the NASDAQ 100?

No, Sana Biotechnology is not included in the NASDAQ 100 index

Is Sana Biotechnology in the Dow Jones?

No, Sana Biotechnology is not included in the Dow Jones index

When was Sana Biotechnology's last earnings report?

Sana Biotechnology's most recent earnings report was on Nov 8, 2024

When does Sana Biotechnology report earnings?

The next expected earnings date for Sana Biotechnology is Feb 28, 2025

Should I buy Sana Biotechnology stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions